Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
Clinical trial NCT00003512 · WITHDRAWN
Trial details
- NCT number
- NCT00003512
- Sponsor
- Burzynski Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-02-18
- Primary completion
- 2000-04-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.